If the nutritional supplements sector is to ever cast off its reputation for ‘dangerous’ and unlabelled contaminants then big online retails must embrace and enforce stricter anti-doping policies, argues Luca Bucchini, PhD.
Controversial ingredient DMAA has been detected in Chinese geranium, according to a new study from Intertek AAC Labs and funded by USPlabs, which challenges other recent studies that demonstrated its absence in the plant.
Australia’s medicines regulator – the Therapeutic Goods Administration (TGA) - has added DMAA to its Schedule 9 list of prohibited substances and poisons that includes cannabis, salvia divinorum, GHB, heroin, psilocybin and LSD.
If last month’s paper in the Journal of Analytical Toxicology was seen by some observers as the ‘final nail in DMAA’s coffin’, a new paper published in Drug Testing and Analysis this month appears to drive that nail home.
They’ve had the sword of Damocles hanging over their heads for months. So when 10 firms selling DMAA supplements were finally told to put up or shut up by the FDA last week, it looked like the game might finally be up for the controversial stimulant.
Trade in sports products containing the controversial stimulant DMAA (methylhexaneamine/1,3-dimethylamylamine) is illegal in the European Union, and should be brought to an immediate halt by EU and member state authorities, according to the Council for...
Portuguese and South Korean athletes have received two-year bans from the International Association of Athletics Federations (IAAF) for methylhexaneamine (DMAA) doping violations at the recent World Championships in South Korea.
Sections of the European botanicals industry are beginning to raise red flags about DMAA, the synthetic stimulant commonly found in sports supplements but often labeled as an extract of geranium plants.